Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Footnotes
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Corrigendum Free access | 10.1172/JCI83084

FOXP3+ regulatory T cell development and function require histone/protein deacetylase 3

Liqing Wang, Yujie Liu, Rongxiang Han, Ulf H. Beier, Tricia R. Bhatti, Tatiana Akimova, Mark I. Greene, Scott W. Hiebert, and Wayne W. Hancock

Find articles by Wang, L. in: PubMed | Google Scholar

Find articles by Liu, Y. in: PubMed | Google Scholar

Find articles by Han, R. in: PubMed | Google Scholar

Find articles by Beier, U. in: PubMed | Google Scholar

Find articles by Bhatti, T. in: PubMed | Google Scholar

Find articles by Akimova, T. in: PubMed | Google Scholar

Find articles by Greene, M. in: PubMed | Google Scholar

Find articles by Hiebert, S. in: PubMed | Google Scholar

Find articles by Hancock, W. in: PubMed | Google Scholar

Published August 3, 2015 - More info

Published in Volume 125, Issue 8 on August 3, 2015
J Clin Invest. 2015;125(8):3304–3304. https://doi.org/10.1172/JCI83084.
Copyright © 2015, American Society for Clinical Investigation
Published August 3, 2015 - Version history
View PDF

Related article:

FOXP3+ regulatory T cell development and function require histone/protein deacetylase 3
Liqing Wang, … , Scott W. Hiebert, Wayne W. Hancock
Liqing Wang, … , Scott W. Hiebert, Wayne W. Hancock
Research Article

FOXP3+ regulatory T cell development and function require histone/protein deacetylase 3

  • Text
  • PDF
Abstract

Treg dysfunction is associated with a variety of inflammatory diseases. Treg populations are defined by expression of the oligomeric transcription factor FOXP3 and inability to produce IL-2, a cytokine required for T cell maintenance and survival. FOXP3 activity is regulated post-translationally by histone/protein acetyltransferases and histone/protein deacetylases (HDACs). Here, we determined that HDAC3 mediates both the development and function of the two main Treg subsets, thymus-derived Tregs and induced Tregs (iTregs). We determined that HDAC3 and FOXP3 physically interact and that HDAC3 expression markedly reduces Il2 promoter activity. In murine models, conditional deletion of Hdac3 during thymic Treg development restored Treg production of IL-2 and blocked the suppressive function of Tregs. HDAC3-deficient mice died from autoimmunity by 4–6 weeks of age; however, injection of WT FOXP3+ Tregs prolonged survival. Adoptive transfer of Hdac3-deficient Tregs, unlike WT Tregs, did not control T cell proliferation in naive mice and did not prevent allograft rejection or colitis. HDAC3 also regulated the development of iTregs, as HDAC3-deficient conventional T cells were not converted into iTregs under polarizing conditions and produced large amounts of IL-2, IL-6, and IL-17. We conclude that HDAC3 is essential for the normal development and suppressive functions of thymic and peripheral FOXP3+ Tregs.

Authors

Liqing Wang, Yujie Liu, Rongxiang Han, Ulf H. Beier, Tricia R. Bhatti, Tatiana Akimova, Mark I. Greene, Scott W. Hiebert, Wayne W. Hancock

×

Original citation: J Clin Invest. 2015;125(3):1111–1123. doi:10.1172/JCI77088.

Citation for this corrigendum: J Clin Invest. 2015;125(8):3304. doi:10.1172/JCI83084.

The GEO accession number provided in Methods was incorrect. The correct sentence is below.

All original microarray data were deposited in the NCBI’s Gene Expression Omnibus (GEO GSE68991).

The authors regret the error.

Footnotes

See the related article beginning on page 1111.

Version history
  • Version 1 (August 3, 2015): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Footnotes
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts